This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Press Archive

Category
Year

ITM and United Imaging team up in strategic partnership to cover Chinese and global cancer imaging markets

ITM and UIH to collaborate in marketing and sales of ITM and UIH imaging and related products to clinical customers in China and worldwide.

Garching/Munich (Germany) and Shanghai (China), April 01, 2019 – ITM Isotopen Technologien München AG (ITM), a group of specialized radiopharmaceutical companies and United Imaging Healthcare Co., Ltd. (UIH), a leader in next generation precision cancer imaging and innovative medical IT solutions, announced today that they have signed an agreement to collaborate in marketing and sales of ITM and UIH imaging and related products to clinical customers in China and worldwide.

ITM holds a leading position in the development, production and, thanks to an unrivalled logistics network, global supply of a new generation of medical radioisotopes, radiopharmaceuticals and equipment whilst UIH is a market forerunner in the development and production of a full portfolio of medical products covering the entire process of diagnostic imaging, radiotherapy and medical information technology.

Hence both companies have strong experience in the field of precision cancer imaging, complementary products as well as similar market objectives. ITM will supply its imaging products to UIH PET/CT installations in China at the same time, it has been agreed that joint efforts will be made to develop new global markets and clinical sites. Since the products of both companies are complex hightech system technologies, small on site teams will be established to take care of direct supplies, trainings for the handling of ITM radionuclides and equipment as well as for processing and application in conjunction with the UIH PET/CT installations. In addition, the collaboration includes innovation and optimization of Precision Oncology imaging, from imaging agents through to image processing, digitization of imaging, patient flows, patient management and patient support.

“We are very excited about our partnership with United Imaging,” said Steffen Schuster, CEO of ITM. “Due to their long-term experience in the diagnostic and radiotherapy market, United Imaging is the right partner for us to expand our business into the dynamic and significant Chinese market. This strategic collaboration is a clear win-win for ITM and United Imaging, as both companies are experiencing significant growth in their core areas, enabling us to collectively expand the supply of radiodiagnostic imaging in Precision Oncology in the Chinese and worldwide market.”

“The strengths and expertise of both companies complement each other very well,” added Al Zhang, Co-President of United Imaging. “Our experience in the field of PET imaging and medical IT solutions coupled with ITM’s production and global supply of next generation radioisotopes in more than 250 sites in 46 countries enables us to open up further markets. The partnership aims to focus our combined energies on a broader customer base and thereby driving growth of both companies in the global cancer imaging market.”

                                                                                               – Ends –

 

About ITM
ITM Isotopen Technologien München AG is a privately held group of companies dedicated to the development, production and global supply of innovative diagnostic and therapeutic radionuclides and radiopharmaceuticals. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of novel, first-in-class medical radionuclides and generator platform for a new generation of targeted cancer diagnostics and therapies. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development, which address a range of cancers such as neuroendocrine cancers and bone metastases. ITM’s main objectives, together with its scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side-effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology. For more information about ITM, please visit: www.itm.ag


About UIH
United Imaging Healthcare Co., Ltd. (UIH) develops and produces a full portfolio of advanced medical imaging and radiotherapy equipment and offers medical IT and intelligent solutions. Founded in 2011 and headquartered in Shanghai, the company has subsidiaries and R&D centers across China, US, and other parts of the world. UIH’s vision is to lead healthcare innovation. Through innovation, UIH aims to contribute to bringing equal healthcare for all people worldwide. To learn more, please visit: www.united-imaging.com

 

ITM Contact
Nicola Scharrer
Head of Marketing
Phone: +49 89 3298986-151
Email: Nicola.Scharrer(at)itm.ag

Media Contact – WE Communications
Sebastian Klein
Senior Account Executive
Phone: +49 89 628175-46
Email: ITM_AG(at)we-worldwide.com

United Imaging Media Contact
Lixia Chen
Senior Manager of PR
Phone: +86 15026402101
Email: lixia.chen(at)united-imaging.com